English
हिन्दी
Latest news
World
Markets
Personal Finance
Healthcare
India
Economy
Politics
Travel
Education & Careers
Sports
Views
Auto
Entertainment
Minis
Branded Content
Accelerate Your Cloud Journey
The Unicorn Makers
Accelerating to a Connected Future
Financial Services Cloud Symposium
Crypto
Education Next
Ey Entrepreneur Of The Year
SMB Saathi
Mf Corner
The Making With Shereen Bhan
IRMA
Wizards of finance
Smart Investor
The Thought League
Ceo awards
Discover CNBCTV18
About
Contact
Advertise
Disclaimer
Terms of Use
Privacy Policy
Shows
Anchors
Trending
#EconomicSurveyLive
#MarketLive
#Budget2023
#WallStreet
#BankingQ3FY23
#Budget2023
#RepublicDay
#CNBCAwaaz
#Storyboard18
#The5gOpportunity
Watch Live TV
English
Hindi
Nifty
Sensex
MCX
Budget 2023
News
Featured
Market
Companies
Personal Finance
Sports
Watch Now
Live TV
Home
Latest News
Featured
Live TV
CNBC-TV18
CNBC Awaaz
CNBC Bajar
Market Live
Minis
Podcasts
CNBC-TV18 Specials
Young Turks
Mind Matters
Climate Clock
Marquee Nights
Photos
Sections
Market
Global Markets
Stocks
Money
Companies
Economy
Cryptocurrency
Terms and Conditions
Disclaimer
Terms of Use
Privacy Policy
home
Molnupiravir News
Molnupiravir NEWS
All
News
Photo
Video
healthcare | Mar 28, 2022 1:07 PM IST
Don’t see opportunity for Paxlovid in EMs; no visibility on market size for Molnupiravir: Laurus Labs
healthcare | Mar 22, 2022 3:25 PM IST
Pfizer to share technology for COVID-19 antiviral drug, Paxlovid
market | Feb 11, 2022 12:41 PM IST
Divi's Labs Q3 Earnings: Profit jumps 92% to Rs 902 crore, beats Street estimates
healthcare | Jan 30, 2022 3:52 PM IST
2 years on, vaccines, following protocols remain most effective weapons against COVID-19
business | Jan 7, 2022 9:03 AM IST
Lupin launches Molnupiravir under brand 'Molnulup' for COVID treatment
healthcare | Jan 7, 2022 7:59 AM IST
How did Molnupiravir become a part of COVID treatment globally? Details here
healthcare | Jan 5, 2022 11:20 PM IST
COVID antiviral drug Molnupiravir has major safety concerns: ICMR chief
healthcare | Jan 4, 2022 6:48 PM IST
Dr Reddy's to launch Molflu at Rs 35 per capsule for COVID treatment
healthcare | Jan 4, 2022 6:32 PM IST
As COVID-19 antiviral Molnupiravir launches in India; here's all you need to know about the pill
market | Dec 29, 2021 2:50 PM IST
Sun Pharma, Dr Reddy's, Divi's, other pharma stocks in high demand on Molnupiravir nod
healthcare | Dec 29, 2021 10:41 AM IST
Molnupiravir unlikely to make big impact on Indian companies: Research Delta Advisors
healthcare | Dec 28, 2021 8:24 PM IST
Dr Reddy's Laboratories to introduce Molnupiravir to treat COVID-19 shortly
healthcare | Dec 28, 2021 5:04 PM IST
Experts' take on 'precautionary dose' and vaccine for kids
healthcare | Dec 28, 2021 9:26 AM IST
SEC grants EUA for anti-COVID pill Molnupiravir after application from 6 pharma firms
healthcare | Dec 2, 2021 2:59 PM IST
UK regulator approves GSK’s COVID antibody 'Xevudy' or 'Sotrovimab'
Shows
View All
Top Budget Opinions
Most Read
Market Movers
View All
Top Gainers
Top Losers
Currency
Commodities
Company
Price
Chng
%Chng